Detalles de la búsqueda
1.
Controlled Human Infection Models To Accelerate Vaccine Development.
Clin Microbiol Rev
; 35(3): e0000821, 2022 09 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35862754
2.
Scientific and regulatory challenges in evaluating clinical trial protocols for HIV-1/AIDS vaccines - A review from a regulatory perspective.
Biologicals
; 44(2): 90-110, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26732973
3.
Review of efficacy trials of HIV-1/AIDS vaccines and regulatory lessons learned: A review from a regulatory perspective.
Biologicals
; 44(2): 73-89, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26776940
4.
Human challenge trials in vaccine development: Strasbourg, September 29 - October 1, 2014.
Biologicals
; 44(1): 37-50, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26611523
5.
WHO informal consultation on regulatory considerations for evaluation of the quality, safety and efficacy of RNA-based prophylactic vaccines for infectious diseases, 20-22 April 2021.
Emerg Microbes Infect
; 11(1): 384-391, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35001848
6.
Evaluation of the human host range of bovine and porcine viruses that may contaminate bovine serum and porcine trypsin used in the manufacture of biological products.
Biologicals
; 39(6): 359-69, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22000165
7.
Mode of action of adjuvants: implications for vaccine safety and design.
Biologicals
; 38(5): 594-601, 2010 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20659806
8.
Mechanism of ad5 vaccine immunity and toxicity: fiber shaft targeting of dendritic cells.
PLoS Pathog
; 3(2): e25, 2007 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-17319743
9.
Toxicological safety evaluation of DNA plasmid vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile virus is similar despite differing plasmid backbones or gene-inserts.
Toxicol Sci
; 91(2): 620-30, 2006 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-16569728
10.
Biodistribution of DNA plasmid vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile virus is similar, without integration, despite differing plasmid backbones or gene inserts.
Toxicol Sci
; 91(2): 610-9, 2006 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-16569729
11.
Now that you want to take your HIV/AIDS vaccine/biological product research concept into the clinic: what are the "cGMP"?
Vaccine
; 33(15): 1757-66, 2015 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-25698494
12.
Systematic evaluation of in vitro and in vivo adventitious virus assays for the detection of viral contamination of cell banks and biological products.
Vaccine
; 32(24): 2916-26, 2014 May 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-24681273
13.
Opinion on adventitious agents testing for vaccines: why do we worry so much about adventitious agents in vaccines?
Vaccine
; 31(26): 2791-5, 2013 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-23528414
14.
Biodistribution and toxicological safety of adenovirus type 5 and type 35 vectored vaccines against human immunodeficiency virus-1 (HIV-1), Ebola, or Marburg are similar despite differing adenovirus serotype vector, manufacturer's construct, or gene inserts.
J Immunotoxicol
; 5(3): 315-35, 2008 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-18830892
15.
Inclusion of adolescents in preventive HIV vaccine trials: public health policy and research design at a crossroads.
J Acquir Immune Defic Syndr
; 47(1): 86-92, 2008 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17984759
16.
Current advances and challenges in HIV-1 vaccines.
Curr HIV/AIDS Rep
; 3(1): 39-47, 2006 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-16522258
Resultados
1 -
16
de 16
1
Próxima >
>>